# HMG (Menotropin)

> Human menopausal gonadotropin — a purified FSH + LH gonadotropin preparation used clinically for ovulation induction and assisted reproduction.

- Also known as: Human menopausal gonadotropin, Menotropin, hMG
- Class: Reproductive
- FDA approved: Yes
- Canonical page: https://americanpeptide.com/catalog/hmg

## Overview

HMG (human menopausal gonadotropin, menotropin) is a biologic preparation of the gonadotropins FSH and LH, purified from the urine of postmenopausal women, in which both follicle-stimulating and luteinizing-hormone activity are present together. It is a long-established, FDA-approved class of fertility medicine used to stimulate the ovaries for ovulation induction and in assisted-reproduction (IVF) protocols, and to support spermatogenesis in some male-infertility settings. Unlike the synthetic peptides in this catalog, HMG is a glycoprotein-hormone mixture, not a solid-phase peptide.

HMG is one of the oldest gonadotropin therapies, extracted and purified from postmenopausal urine, which is naturally rich in FSH and LH. Its value is that it delivers both activities at once — follicular stimulation and luteinizing support — which is why it has long been used to drive controlled ovarian stimulation in fertility care.

It is a biologic glycoprotein mixture rather than a defined synthetic peptide, and purified and recombinant gonadotropins (recombinant FSH, for example) are the modern refinements of the same idea. It sits in this catalog alongside the other reproductive-axis entries (hCG, FSH, gonadorelin). HMG is an approved medicine used under clinical supervision; this page is a research and educational reference, not medical advice.

## Mechanism

Combined FSH and LH receptor agonism: FSH drives ovarian follicular growth, LH supports steroidogenesis and, with hCG, final maturation. In men, FSH plus LH activity supports testicular function and sperm production.

## Research areas

Studied in: Ovulation induction, Assisted reproduction (IVF), Male hypogonadotropic infertility.

## Key research

- FSH + LH together — a purified gonadotropin preparation delivering both activities in one product.
- Ovulation induction / IVF — a mainstay of controlled ovarian stimulation in assisted reproduction.
- Urine-derived biologic — purified from postmenopausal urine; a glycoprotein mixture, not a synthetic peptide.
- FDA-approved class — an established fertility medicine, used clinically (unlike most research peptides here).

## Storage, handling & synthesis

**Storage.** Supplied and stored as a lyophilized biologic under refrigeration; reconstituted gonadotropin is used promptly. Follow the approved product’s labeling — this is a clinical medicine, not a research reagent.

**Handling.** Handle as a glycoprotein biologic: heat- and agitation-sensitive, reconstituted gently. Its quality is measured as gonadotropin activity and freedom from other urinary proteins, not as a solid-phase synthesis spec.

**Synthesis.** Not a synthetic peptide. HMG is a biologic purified from the urine of postmenopausal women, containing the glycoprotein hormones FSH and LH. There is no solid-phase synthesis — identity and potency are set by bioassay or immunoassay of FSH and LH activity, not by a peptide certificate, and "purity" means removing other urinary proteins. Recombinant FSH is the modern, more defined alternative to the extracted product.

## FAQs

### What is HMG?

Human menopausal gonadotropin (menotropin) — a purified preparation of FSH and LH from postmenopausal urine, used clinically to stimulate the ovaries for fertility treatment.

### How is it different from the peptides in this catalog?

HMG is a biologic glycoprotein-hormone mixture, not a synthetic solid-phase peptide, and it is an FDA-approved medicine rather than a research compound.

### What is it used for?

Ovulation induction and assisted-reproduction (IVF) protocols, and some male-infertility settings — always under clinical supervision.

### Is it approved?

Yes — menotropins are an approved class of fertility medicine. This page is a research and educational reference, not medical advice.

## Latest research

Recent trials and publications mentioning Human menopausal gonadotropin, pulled automatically from ClinicalTrials.gov and PubMed (unfiltered search results, refreshed daily).

### Recent trials

- [A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)](https://clinicaltrials.gov/study/NCT07340827) — RECRUITING · PHASE3 · NCT07340827
- [Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.](https://clinicaltrials.gov/study/NCT07216742) — ACTIVE_NOT_RECRUITING · PHASE3 · NCT07216742
- [Late-Start Corifollitropin Alfa in Mild Ovarian Stimulation](https://clinicaltrials.gov/study/NCT07891793) — COMPLETED · NA · NCT07891793
- [Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle](https://clinicaltrials.gov/study/NCT07453069) — RECRUITING · PHASE2 · NCT07453069
- [HMG Treatment Reduces Sperm DNA Fragmentation](https://clinicaltrials.gov/study/NCT07873502) — COMPLETED · PHASE1 · NCT07873502
- [Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer](https://clinicaltrials.gov/study/NCT02003209) — COMPLETED · PHASE3 · NCT02003209

---

Source: AmericanPeptide.com — https://americanpeptide.com/catalog/hmg
Data license: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Attribution: AmericanPeptide.com.
Research reference only — computational and educational content, not medical advice.